Trial Profile
Renin Observed with Added Dapagliflozin - an Evaluation under Unexceptional RAS Inhibitor Administration.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ROAD-EURASIA
- 27 Mar 2019 Status changed from active, no longer recruiting to discontinued.
- 27 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Jul 2016 Status changed from not yet recruiting to recruiting.